drugset

drugset / Trial / NCT01621399

Safety and Efficacy Study to Treat Bacterial Vaginosis

NCT01621399 ↗

Phase 3 Completed 651 enrolled Medicis Global Service Corporation

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if product 55394 is safe and efficacious for the treatment of bacterial vaginosis.

Timeline

Start: 2012-05
Primary completion: 2012-10
Completion: 2012-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Product 55394	Unknown	—	Other

Indications